Raynovent Announces Approval of Investigational New Drug (IND) Application of Category 1 Drug ZSP0678 for a New Indication

Previous:No articles

Next:Dr. Chen Xiaoxin, Vice President of Raynovent was Invited to Attend CHBD Year-end Party - Shenzhen Station.